APOE and Alzheimer disease: APOE ε4 allele, usually existing in approximately 15% of people, lowers the age of AD onset and increases the risk of AD in a dose-dependent manner (Levy et al., 1990; Wallon et al., 2012; Ward et al., 2012; Tang et al., 2016).